금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Euro: Gradual upside as Fed and ECB converge – Commerzbank
Commerzbank economists, led by Dr. Jörg Krämer and colleagues, expect the Fed and ECB to keep rates ...
Gold slides to a 3-month low below $4,000: 3 analysts agree it's under pressure, and disagree on the floor
Gold (XAU/USD) has tumbled below $4,000 to a fresh three-month low as surging Oil prices revive infl...
The IMF Just Raised Its Economic Growth Forecast. Buried in the Report Is a Warning for Stock Investors.
Economic growth is becoming increasingly reliant on one theme and a smaller number of economies....
You might be shocked by how many stocks are in a bear market right now
The S&P 500 was trading within 2 percentage points of its record closing high on Tuesday, but dig a little bit deeper, and things are looking far less rosy.
ECB’s DeMarco backs October hike as core inflation stays firm
Alexander DeMarco, the Governor of the Central Bank of Malta and member of the Governing Council of the European Central Bank (ECB), crossed the wires on Tuesday, saying that “stronger core inflation” ...
Demand Stabilization Fuels Charles River Laboratories International’s (CRL) Recovery
Cooke & Bieler, an investment management firm, released its second-quarter investor letter for “Mid Cap Value Equity Strategy.” The letter can be downloaded here. U.S. equities rallied significantly i ...
Cruise Stocks Jump After Carnival Posts Strong Results and Rosy Outlook
Cruise stocks are surging after results from an industry leader topped Wall Street’s expectations.
MKS (MKSI) Gains on Rising AI Semiconductor Demand
Cooke & Bieler, an investment management firm, released its second-quarter investor letter for “Mid Cap Value Equity Strategy.” The letter can be downloaded here. U.S. equities rallied significantly i ...
What Makes Tetra Tech (TTEK) a Bullish Bet?
Cooke & Bieler, an investment management firm, released its second-quarter investor letter for “Mid Cap Value Equity Strategy.” The letter can be downloaded here. U.S. equities rallied significantly i ...
Iovance Stock Surges as Strong Melanoma Drug Demand Drives Growth
Shares of Iovance Biotherapeutics surged Tuesday after the biotech company raised its fiscal-year revenue guidance, thanks to rising demand for a pair of melanoma treatments. Iovance stock rose 28% ...
3 Reasons to Avoid TLYS and 1 Stock to Buy Instead
While the S&P 500 is up 22.1% since March 2026, Tilly's (currently trading at $4.47 per share) has lagged behind, posting a return of 12.8%. This may have investors wondering how to approach the situa ...
Bloom Energy stock gains on factory expansion, fuel-cell demand outlook
Spotify, Claude face disruptions as user reports surge
3 Reasons to Avoid YETI and 1 Stock to Buy Instead
YETI trades at $43.05 and has moved in lockstep with the market. Its shares have returned 21.2% over the last six months while the S&P 500 has gained 22.1%.
Activist Irenic plans to vote against Independence Realty's purchase of Centerspace